Your browser doesn't support javascript.
loading
Global reporting of progress towards elimination of hepatitis B and hepatitis C.
Cui, Fuqiang; Blach, Sarah; Manzengo Mingiedi, Casimir; Gonzalez, Monica Alonso; Sabry Alaama, Ahmed; Mozalevskis, Antons; Séguy, Nicole; Rewari, Bharat Bhushan; Chan, Po-Lin; Le, Linh-Vi; Doherty, Meg; Luhmann, Niklas; Easterbrook, Philippa; Dirac, Mae; de Martel, Catherine; Nayagam, Shevanthi; Hallett, Timothy B; Vickerman, Peter; Razavi, Homie; Lesi, Olufunmiayo; Low-Beer, Daniel.
Afiliación
  • Cui F; School of Public Health, Peking University, Beijing, China.
  • Blach S; Center for Disease Analysis Foundation, Lafayette, CO, USA.
  • Manzengo Mingiedi C; WHO Regional Office for Africa, Brazzaville, Republic of Congo.
  • Gonzalez MA; WHO Regional Office for the Americas, Washington, DC, USA.
  • Sabry Alaama A; WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt.
  • Mozalevskis A; WHO Regional Office for Europe, Copenhagen, Denmark.
  • Séguy N; WHO Regional Office for Europe, Copenhagen, Denmark.
  • Rewari BB; WHO Regional Office for South- East Asia, New Delhi, India.
  • Chan PL; WHO Regional Office for the Western Pacific, Manila, Philippines.
  • Le LV; WHO Regional Office for the Western Pacific, Manila, Philippines.
  • Doherty M; WHO Headquarters, Geneva, Switzerland.
  • Luhmann N; WHO Headquarters, Geneva, Switzerland.
  • Easterbrook P; WHO Headquarters, Geneva, Switzerland.
  • Dirac M; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • de Martel C; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Nayagam S; Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
  • Hallett TB; Faculty of Medicine, School of Public Health, Imperial College London, London, UK.
  • Vickerman P; Population Health Sciences, University of Bristol, Bristol, UK.
  • Razavi H; Center for Disease Analysis Foundation, Lafayette, CO, USA.
  • Lesi O; WHO Headquarters, Geneva, Switzerland.
  • Low-Beer D; WHO Headquarters, Geneva, Switzerland. Electronic address: lowbeerd@who.int.
Lancet Gastroenterol Hepatol ; 8(4): 332-342, 2023 04.
Article en En | MEDLINE | ID: mdl-36764320

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis B Crónica / Hepatitis C Crónica / Hepatitis A / Hepatitis B / Hepatitis Viral Humana Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis B Crónica / Hepatitis C Crónica / Hepatitis A / Hepatitis B / Hepatitis Viral Humana Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos